What is the recommended ceftriaxone dosage for a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftriaxone Dosing in Children

For most pediatric infections, ceftriaxone should be dosed at 50-75 mg/kg/day given once daily or divided every 12 hours, with a maximum of 2 grams per day. 1

Standard Dosing by Indication

Common Infections (Non-Meningitis)

  • Dose: 50-75 mg/kg/day
  • Frequency: Once daily OR divided every 12 hours
  • Maximum: 2 grams/day
  • Route: IV or IM
  • Indications: Skin/soft tissue infections, pneumonia, complicated intra-abdominal infections, urinary tract infections 1, 2, 3

Bacterial Meningitis

  • Initial dose: 100 mg/kg (not to exceed 4 grams)
  • Maintenance: 100 mg/kg/day (maximum 4 grams/day)
  • Frequency: Once daily OR divided every 12 hours
  • Duration: 7-14 days typically 1, 4

Important consideration: Recent pharmacokinetic data suggests once-daily dosing (100 mg/kg) achieves better CSF penetration and earlier target attainment than twice-daily dosing (50 mg/kg BID) for meningitis 5. The once-daily regimen achieved 88% probability of target attainment at 24 hours versus only 53% for twice-daily dosing.

Acute Otitis Media

  • Dose: 50 mg/kg IM
  • Frequency: Single dose
  • Maximum: 1 gram
  • Note: This is for treatment failures or when oral therapy is not feasible 1, 4

Febrile Infants (8-60 Days Old)

  • Dose: 50 mg/kg
  • Frequency: Once daily
  • Route: IV or IM
  • Context: For empiric therapy when UTI or bacteremia suspected 6

Age-Specific Considerations

Neonates (≤28 Days)

  • Standard dose: 50 mg/kg/day once daily
  • Meningitis dose: 100 mg/kg/day divided every 12 hours
  • Critical safety point: Administer IV doses over 60 minutes (not 30 minutes) to reduce risk of bilirubin encephalopathy 4
  • Contraindication: Do NOT use in hyperbilirubinemic neonates due to displacement of bilirubin from albumin binding sites 4

Infants and Children (>28 Days)

  • Standard dosing as above applies
  • IV infusions can be given over 30 minutes 4

Clinical Pearls

Advantages of once-daily dosing:

  • Equivalent efficacy to divided dosing 7, 8
  • Greater ease of administration
  • Facilitates outpatient parenteral therapy
  • Better CSF penetration for meningitis 5
  • Maintains therapeutic levels throughout 24-hour interval 7

When to use higher doses (75-100 mg/kg/day):

  • Severe infections
  • Meningitis
  • Resistant pneumococcal infections (MIC ≥4.0 µg/mL) 2, 3
  • Patients requiring mechanical ventilation 9

Dosing adjustments:

  • Renal/hepatic impairment: No adjustment needed for doses up to 2 grams/day 4
  • Elderly patients: No adjustment needed 4

Common Pitfalls to Avoid

  1. Do not exceed maximum doses: 2 grams/day for non-meningitis infections, 4 grams/day for meningitis
  2. Avoid in neonates with jaundice: Risk of kernicterus from bilirubin displacement
  3. Do not mix with calcium-containing solutions: Risk of precipitation 4
  4. Infusion rate in neonates: Must be 60 minutes, not 30 minutes
  5. For S. aureus infections: Ceftriaxone alone is inadequate; add vancomycin or clindamycin 2, 3

Specific Infection Protocols

Community-acquired pneumonia (hospitalized):

  • Ceftriaxone 50-100 mg/kg/day once daily 2, 3
  • Add macrolide if atypical pathogens suspected
  • Add vancomycin/clindamycin if MRSA suspected

Complicated intra-abdominal infection:

  • Ceftriaxone 50-75 mg/kg/day every 12-24 hours
  • Must add metronidazole for anaerobic coverage 1

Acute bacterial sinusitis (treatment failure):

  • Single IM dose of 50 mg/kg (maximum 1 gram)
  • Can repeat daily for 3 days if needed 10

The evidence strongly supports once-daily dosing for most indications, with the notable exception that neonates with meningitis may benefit from divided dosing due to their unique pharmacokinetics 11, 12.

References

Research

Pharmacokinetics and safety of ceftriaxone in the neonate.

European journal of pediatrics, 1985

Research

Single-dose ceftriaxone kinetics in the newborn.

Clinical pharmacology and therapeutics, 1985

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.